Biohealth Innovation
Click here to view original article »
 

You're receiving this newsletter because of your interest in BioHealth Innovation
Having trouble viewing this email? View it in your browser.

Apr 5, 2016
NEWS
 
ABOUT US PROGRAMS PARTNERS CLIENTS NEWS EVENTS CONTACT
 
NEWS
 
EVENTS
 
JOBS
 
 
 
Gaithersburg's MaxCyte lists on the London Stock Exchange, plans to begin immunotherapy drug development - Washington Business Journal

Gaithersburg cell modification technology firm MaxCyte Inc. is expected to go public on the London Stock Exchange Tuesday morning.

MaxCyte, which will trade under the ticker symbol MXCT, is seeking to raise between $14 million and $15 million, said CEO and President Doug Doerfler.

READ MORE
 
 
 
 
Neopenda: Wearable Vital Signs Monitor for Newborns by Neopenda — Kickstarter

Our mission: improve newborn survival and health in the developing world

We are developing cutting edge healthcare technologies for where they’re gravely needed and will have an incredible impact—vulnerable populations in low-resource countries. Annually, over 46 million newborns in developing countries around the world need interventions for complications that happen at or around birth, 600,000 in Uganda alone. Every Neopenda device has the potential to save the life of a newborn for less than $1, once it is produced at scale.

READ MORE
MITRE CYBER INNOVATION NIGHT

May 11, 2016 5:30 p.m. - 8:30 p.m.

The MITRE Corporation McLean Campus, MITRE 2 7515 Colshire Drive McLean, VA 22102

Please join us at the MITRE Corporation on the evening of May 11, 2016, for an event that will bring together cyber technology providers, entrepreneurs, investment companies, and others interested in hearing about the latest in available cyber technologies and products.

Reasons to attend:

  • Discover emerging technologies that could be game changers
  • Hear pitches and get demos on innovative technologies from MITRE and other regional companies
  • Learn about U.S. government's need in the cyber domain Network with individuals, investors and companies impacting the region's technology ecosystem
READ MORE
Bloomberg, others give $125M to Johns Hopkins for new cancer research center - Baltimore Business Journal

Johns Hopkins is launching an immunotherapy center for cancer research with a $125 million gift from longtime Hopkins donors Michael R. Bloomberg and Sidney Kimmel, along with other donors.

READ MORE
Johns Hopkins University's immunotherapy institute aims to transform cancer treatment - Washington Business Journal

Johns Hopkins is setting its sights on an end to cancer with its new Bloomberg-Kimmel Institute for Cancer Immunotherapy.

READ MORE
Federal Laboratories Consortium Presents: Small Business Forum - April 12, 2016

Are you a local engineering firm, technology-based company, or biohealth startup? Are you a STEM-based business in the Tri-State area? The Federal Laboratory Consortium is coming to Hagerstown on April 12, 2016 to share the latest technologies and research capabilities of the federal labs. NIST, NSA, NASA, NIH, & USDA will all be at Hagerstown Community College for the Small Business Forum from 9 a.m. to 3:30 p.m. Connect with representatives from each lab and discover how you can benefit from working with their lab.

READ MORE
Montgomery County Offers International Business Opportunities

Eight small and mid-sized Montgomery County companies have been awarded ExportMD grants by the Maryland Department of Commerce to help promote their products and services in the global marketplace. The state awarded a total of 16 grants and the lion’s share went to local businesses. The companies receiving grants are: American General Supplies; Care Systems, Inc.; MagBio Genomics; Molecular Transfer, Inc.; Patton Electronics Co.; PW Communications; Rife International, LLC; and Washington Laboratories.

READ MORE
University of Maryland spinout VisiSonics hits the market with its 3-D sound technology - Baltimore Business Journal

Ramani Duraiswami is the first person to admit that you have to try his technology to truly understand what it is.

READ MORE
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors - Xconomy

The Alexandria Center for Life Science currently houses some of the most ambitious biotech startups in New York, not to mention some outposts for pharma companies like Roche and Pfizer. Not bad for something that, as Alexandria Real Estate Equities CEO Joel Marcus said, “was a contaminated laundry site” just a short time ago.

READ MORE
Johns Hopkins performs first transplants between donors, recipients infected with HIV - Baltimore Sun

Johns Hopkins Medicine has performed the nation's first liver and kidney transplants from a donor infected with HIV to recipients also infected with the virus, a triumph for one of the transplant surgeons, who fought for six years for federal approval of the life-saving surgery.

READ MORE
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01)

As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First), the NIH invites applications to use whole genome sequencing at a Kids First-supported sequencing center to elucidate the genetic contribution to childhood cancers, and to investigate the genetic etiology of structural birth defects. These data will become part of the Gabriella Miller Kids First Pediatric Data Resource (Kids First Data Resource) for the pediatric research community.

READ MORE
GSK Pharma to launch more combination vaccines - Business Standard News

GlaxoSmithKline Pharmaceuticals Ltd is looking at launching two or three combination vaccines in India in the near future, to address a host of paediatric disease. The company is also organising programmes to spread awareness about the need of vaccination among public.

READ MORE
Spotlight: Linda Cruz-Carnall, Regional Director, Philadelphia Regional Office

There is an element of synchronicity associated with blogging at this time on my work and career path at the U.S. Department of Commerce Economic Development Administration (EDA). On March 28th, I will celebrate 28 years with the Philadelphia Regional Office of EDA so in some ways, I AM living history here at DOC, part of the EDA institutional knowledge base. EDA is celebrating its 50th anniversary in 2016 and I am proud to carry the torch cheerleading for and at EDA, a DOC program that has invested and leveraged billions of dollars in its role as the only federal agency focused exclusively on economic development.

READ MORE
Steve and Jean Case invest in 1776 startup incubator - The Washington Post

The Washington-based start-up incubator known as 1776 has received a $7.2 million investment from Steve and Jean Case and others to help the for-profit consultant find and grow more small businesses throughout the world.

Leading the investment in 1776 is the Pepper Group, a technology investment firm based in Australia. Several unnamed investors also participated.

READ MORE
Exploring This Huge Virtual Heart Showed Me The Future Of Medicine - Co.Design

I stand, a cyborg micronaut, in front of the biggest human heart any person has ever seen.

It is Arch Obler huge, a flesh pump the size of a skyscraper, but I manipulate it with god-like facility, rotating it in midair with my hands and bisecting it with just a flick of the finger. Through ventricles and thundering aorta I dive, floating through heart chambers so enormous, they become corpuscle cathedrals.

READ MORE
J. Craig Venter Institute unveils bacterium with smallest functional genome | SanDiegoUnionTribune.com

Nearly six years after developing the first self-replicating life form with a chemically created genome, scientists at the J. Craig Venter Institute in La Jolla have cut that bacterium's genome nearly in half. The result is a creature with a smaller genome than has ever been found in nature.

READ MORE
Paper Diagnostic Tests Could Save Thousands of Lives - Scientific American

When someone with a high fever walks into a rural African clinic, diagnosis could be murky. The symptoms could be those of dengue, Ebola, West Nile disease, malaria or flu, and blood work results from distant labs, if available, often takes days. Now a handful of researchers are separately working on inexpensive, paper-based diagnostic tests that accurately pinpoint the cause of a disease in minutes and could speed up treatment and prevent its spread. The lack of funds and commercial partners however, means most might languish in labs.

READ MORE
Mach37 Cybersecurity Accelerator: Spring 2016 Cohort

The cybersecurity industry is predicted to double by 2020 and the DC metro area is the center of cybersecurity innovation in the US. Therefore it should be no surprise that the premiere accelerator for information security startups and entrepreneurs calls this area home. The accelerator is Mach37 and they’ve just announced their most recent cohort.

READ MORE
10 Most Common Questions from Physician Entrepreneurs | Arlen Meyers, MD, MBA - LinkedIn

Physician entrepreneurs or wannapreneurs ask a lot of questions about the processes of biomedical and clinical innovation and entrepreneurship. Given their lack of training in medical school, it comes as no surprise and most have to get the information on their own. Maybe these answers to your FAQs will help:

READ MORE
Rankings - 2016 - Best Pharma Brands - InterbrandHealth

Best Pharma Brands, a global study, identifies the biopharma companies that are addressing healthcare professionals’ (HCPs), payers’, and policy makers’ needs. The study examines what value means to HCPs and illustrates the influence the corporate brand has in conveying that value. It reveals how leading companies are beginning to deliver on what matters to HCPs.

READ MORE
 
 
 
 

EVENTS

 

JOBS

 
 
CYBER RISK MANAGEMENT 360
Apr 7
Life Science Investment Fund
Apr 15
REGISTER FOR JHU BME CBID Design Day
May 3
2016 Health Datapalooza
May 8
 
Job Opportunity: Technology Transfer and Patent Specialist (GS-13) at NIH
Calibration Technician – Senior Tech Level
Job Opportunity: Technology Transfer and Patent Specialist (GS-14) at NIH
Frederick Innovative Technology Center, Inc. (FITCI) Director
 
 

Home | About BHI | BHI News | Programs | Partners | Contact
Copyright © BioHealth Innovation 2012
All Rights Reserved. 
22 Baltimore Road Rockville, MD 20850
Subscribe

 
 
The information contained in this website and newsletters is for general information purposes only. The information is provided by BioHealth Innovation via its newsletters, but not written or endorsed in any way by BioHealth Innovation unless otherwise noted. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.